C57BL/6JCya-Dnajc19em1/Cya
Common Name
Dnajc19-KO
Product ID
S-KO-12404
Backgroud
C57BL/6JCya
Strain ID
KOCMP-67713-Dnajc19-B6J-VA
When using this mouse strain in a publication, please cite “Dnajc19-KO Mouse (Catalog S-KO-12404) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Dnajc19-KO
Strain ID
KOCMP-67713-Dnajc19-B6J-VA
Gene Name
Product ID
S-KO-12404
Gene Alias
1810055D05Rik, Tim14
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 3
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000011029
NCBI RefSeq
NM_001026211
Target Region
Exon 2~5
Size of Effective Region
~1.5 kb
Overview of Gene Research
DNAJC19, a member of the DNAJ heat shock protein (Hsp40) family, is located within the inner mitochondrial membrane. It plays a crucial role in regulating the function and localization of mitochondrial Hsp70 (MtHsp70) and is involved in mitochondrial protein import machinery [3,5]. It also forms a complex with prohibitins to regulate cardiolipin remodeling, which is essential for mitochondrial morphogenesis [4].
Mutations in DNAJC19 cause Dilated Cardiomyopathy with Ataxia Syndrome (DCMA). In human iPSC-derived cardiomyocytes with mutant DNAJC19 lacking the conserved DnaJ interaction domain, there are mitochondrial fragmentation, abnormal cristae formation, increased mitochondrial respiration, and altered substrate utilization [2]. In NSCLC, DNAJC19 expression is higher in tumors than adjacent non-cancerous tissues. shRNA-mediated knockdown of DNAJC19 in A549 lung cancer cells inhibits cell growth, viability, migration, and invasion, and represses tumor xenograft growth and lung metastasis by regulating the PI3K/AKT signaling pathway [1].
In conclusion, DNAJC19 is essential for mitochondrial function, including mitochondrial morphogenesis and cardiolipin remodeling. Its dysregulation is associated with DCMA and NSCLC. Studies using gene-edited cell lines and knockdown models in cancer cells have revealed its role in these disease conditions, providing potential therapeutic targets.
References:
1. Zhou, Ji, Peng, Yang, Gao, Ying-Chun, Liu, Tao, Ren, Tao. 2021. Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling. In Cancer cell international, 21, 338. doi:10.1186/s12935-021-02054-z. https://pubmed.ncbi.nlm.nih.gov/34217321/
2. Janz, Anna, Walz, Katharina, Cirnu, Alexandra, Duff, Henry J, Gerull, Brenda. 2023. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes. In Molecular metabolism, 79, 101859. doi:10.1016/j.molmet.2023.101859. https://pubmed.ncbi.nlm.nih.gov/38142971/
3. Al Tuwaijri, Abeer, Alyafee, Yusra, Alharbi, Mashael, Umair, Muhammad, Alfadhel, Majid. 2022. Novel homozygous pathogenic mitochondrial DNAJC19 variant in a patient with dilated cardiomyopathy and global developmental delay. In Molecular genetics & genomic medicine, 10, e1969. doi:10.1002/mgg3.1969. https://pubmed.ncbi.nlm.nih.gov/35611801/
4. Richter-Dennerlein, Ricarda, Korwitz, Anne, Haag, Mathias, Rugarli, Elena I, Langer, Thomas. 2014. DNAJC19, a mitochondrial cochaperone associated with cardiomyopathy, forms a complex with prohibitins to regulate cardiolipin remodeling. In Cell metabolism, 20, 158-71. doi:10.1016/j.cmet.2014.04.016. https://pubmed.ncbi.nlm.nih.gov/24856930/
5. Chen, Guangduo, Bai, Rui, Huang, Pufeng, Ni, Jie, Chen, Lianglong. 2024. Generation of a homozygous DNAJC19 knockout human embryonic stem cell line by CRISPR/Cas9 system. In Stem cell research, 77, 103427. doi:10.1016/j.scr.2024.103427. https://pubmed.ncbi.nlm.nih.gov/38696852/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
